Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study).

MLA

Lorini, L., et al. “Expression of PDL-1 between Primary and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Bi-Institutional Retrospective Concordance Analysis (CONCORDL-1 Study).” Oral Oncology, vol. 157, Oct. 2024, p. 106950. EBSCOhost, https://doi.org/10.1016/j.oraloncology.2024.106950.

APA

Lorini, L., Zigliani, G., Morbini, P., Salviato, E., Piazza, C., Battocchio, S., Preda, L., Benazzo, M., Ravanelli, M., Mattavelli, D., & Bossi, P. (2024). Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study). Oral Oncology, 157, 106950. https://doi.org/10.1016/j.oraloncology.2024.106950

Chicago

Lorini, L, G Zigliani, P Morbini, E Salviato, C Piazza, S Battocchio, L Preda, et al. 2024. “Expression of PDL-1 between Primary and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Bi-Institutional Retrospective Concordance Analysis (CONCORDL-1 Study).” Oral Oncology 157 (October): 106950. doi:10.1016/j.oraloncology.2024.106950.